Latterell Venture Partners

Total investments

55

Average round size

25M

Portfolio companies

27

Rounds per year

2.39

Lead investments

7

Follow on index

0.51

Exits

19

Stages of investment
Private EquityEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologyAnalyticsHealth CareManufacturingMedical DeviceMedicalLife SciencePharmaceuticalTherapeuticsBiopharma

Summary

In 2001 was created Latterell Venture Partners, which is appeared as VC. The company was established in North America in United States. The main department of described VC is located in the San Francisco.

The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Latterell Venture Partners, startups are often financed by DeNovo Ventures, Morgenthaler Ventures, Adams Street Partners. The meaningful sponsors for the fund in investment in the same round are The Vertical Group, Morgenthaler Ventures, Adams Street Partners. In the next rounds fund is usually obtained by DeNovo Ventures, Adams Street Partners, Morgenthaler Ventures.

Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. The fund has exact preference in some founders of portfolio startups. If startup sums 3 or 5+ of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight Pulmonx, TetraLogic Pharmaceuticals, Neuraltus Pharmaceuticals. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. We can highlight the next thriving fund investment areas, such as Analytics, Pharmaceutical.

This organization was formed by Larry Lasky, Pat Latterell. Besides them, we counted 2 critical employees of this fund in our database.

The high activity for fund was in 2012. The top amount of exits for fund were in 2016. The usual things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this VC is 1 percentage points more often commits exit comparing to other companies. Comparing to the other companies, this Latterell Venture Partners performs on 1 percentage points more the average number of lead investments. The fund is constantly included in 2-6 investment rounds annually.

Show more

Investments analytics

Analytics

Total investments
55
Lead investments
7
Exits
19
Rounds per year
2.39
Follow on index
0.51
Investments by industry
  • Health Care (37)
  • Biotechnology (34)
  • Medical Device (24)
  • Medical (22)
  • Pharmaceutical (18)
  • Show 15 more
Investments by region
  • United States (54)
  • South Korea (1)
Peak activity year
2012

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
18
Avg. valuation at time of investment
66M
Group Appearance index
0.96
Avg. company exit year
9
Avg. multiplicator
1.68
Strategy success index
0.30

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company nameDeal dateIndustryDeal stageDeal sizeLocation
MIT Technology Review01 Sep 2016Internet, News, Digital MediaSeed463KChina, Beijing, Haidian District
PerceptiMed27 Mar 2015Health Care, Medical Device, MedicalEarly Stage Venture5MUnited States, California, Mountain View
Talima Therapeutics29 May 2007Biotechnology, Pharmaceutical, TherapeuticsEarly Stage Venture19MUnited States, California
Urban SDK25 Nov 2020Government, Transportation, Software, Analytics, Public Transportation, Smart Cities, Law Enforcement, Civil EngineeringEarly Stage VentureUnited States, Florida, Jacksonville

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.